August31 , 2026

    DSV Launches ‘Indy Wings’ Route to Strengthen Pharma Cold-Chain Connectivity

    Related

    NSDT Sets New Break-Bulk Cargo Handling Record at JNPA

    Nhava Sheva Distribution Terminal (NSDT), managed by JM Baxi...

    Chennai Port Authority Offers Facilitation for Container Vessels Amid Maritime Disruptions

    Chennai Port Authority has announced measures to facilitate container...

    JNPA Explores Strategic Rail Nodes on DFC to Boost Container Evacuation to Bhiwandi

    The Jawaharlal Nehru Port Authority (JNPA) is exploring the...

    Indian Traders Suspend Cross-Border Trade Through Hili Port

    Cross-border import and export operations through the Hili land...

    GRSE Secures Orders from West Bengal for Hybrid Ferries and Bailey Bridges

    Garden Reach Shipbuilders and Engineers (GRSE) Ltd, a Navratna...

    Share

    Global logistics company DSV has expanded its Air ThermoDirect network with the introduction of a new direct air cargo connection between Indianapolis and Luxembourg, known as “Indy Wings”, aimed at enhancing temperature-controlled logistics for the pharmaceutical and healthcare sectors.

    The new route strengthens cold-chain connectivity between Indianapolis—one of the fastest-growing life sciences and healthcare hubs in the United States—and Luxembourg, a major European pharmaceutical gateway. The service is designed to provide greater supply chain control, improved visibility, and faster movement of temperature-sensitive healthcare products across key global trade lanes.

    To mark the launch, DSV hosted customers, partners, industry stakeholders, and local officials at Indianapolis International Airport on 11 June. Attendees were given a behind-the-scenes look at the company’s dedicated aircraft operations and temperature-controlled healthcare facilities, highlighting how integrated logistics solutions support the safe transportation of critical pharmaceutical shipments.

    According to DSV, the direct connection reduces transit time in uncontrolled environments and streamlines handling processes, helping safeguard product integrity while improving operational reliability, cost efficiency, and sustainability performance.

    “The Indianapolis operations will play a pivotal role in enhancing end-to-end visibility and control across key pharma regions, helping ensure that life-saving therapies move with greater speed, reliability and integrity,” said Kenneth Källström, Executive Vice President and Global Head of Healthcare at DSV.

    The launch comes amid growing healthcare and biotechnology investments across the U.S. Midwest, where leading pharmaceutical and biotech companies are driving demand for advanced temperature-controlled logistics infrastructure. The new Indianapolis–Luxembourg route is expected to support this growth by providing a more predictable and scalable transportation solution for high-value healthcare products.